| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |